Tradestie Institutional Equity Comparison Engine

SLS vs CAMP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLS Overall Edge

SLS Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SELLAS Life Sciences Group, Inc. Common Stock (SLS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SLS trades at N/M Forward P/E with 0.0% operating margin (-82.5% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, SLS sits in BREAKOUT (74th %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SLS N/M vs CAMP N/M Fwd P/E
Growth & Margin Winner SLS
Op Margin 0.0% vs -991.8% ยท YoY -82.5% vs +138.9%
Momentum & Technical Winner SLS
1Y +1239.2% vs -2.4% ยท 52W Pos 76% vs 23%
Options & Structure Winner SLS
BREAKOUT (74th %ile IV) vs UNCLASSIFIED (N/A IV)
SLS NASDAQ
SELLAS Life Sciences Group, Inc. Common Stock
Pharmaceutical Preparations
$19.15
+156.36% 1D
Market Cap $1.6B
1M Return +82.55%
1Y Return +1239.16%
Forward P/E N/M
Unified AI Score
34.1 / 100 SELL
Tech 5.0 Fund 37.0 Flow 66.0 Mom 38.9
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap $238.5M
1M Return +27.39%
1Y Return -2.44%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SLS +1239.16% CAMP -2.44% Spread: +1241.6 pp (SLS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SLS Revenue CAMP Revenue SLS Op. Margin CAMP Op. Margin Margin Edge
FY2013 $0M N/A -1145.5% N/A SLS
FY2014 $10M N/A -471.1% N/A SLS
FY2020 $0M N/A -893.8% N/A SLS
FY2021 $10M N/A -332.8% N/A SLS
FY2022 $0M N/A -4195.0% N/A SLS
FY2023 N/A $0M N/A -14822.6% CAMP
FY2024 N/A $0M N/A -8142.3% CAMP
FY2025 N/A $0M N/A -1502.4% CAMP

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SLS (4) vs CAMP (3)
Institutional Metric SLS CAMP Criterion Row Winner
Market Capitalization Scale $1.6B $238.5M Larger Scale SLS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -82.5% +138.9% Higher Growth CAMP
Operating Margin (TTM) Profitability 0.0% -991.8% Higher Margin SLS
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -40.3% -146.1% Higher ROE SLS
52-Week Range Position Momentum 76% ($1โ€“$25) 23% ($3โ€“$8) Stronger Trend SLS
Beta / 30D Volatility Risk Regime 1.38ฮฒ ยท 568% Vol 1.35ฮฒ ยท 94% Vol Lower Realized Risk CAMP
Unified Institutional Score Composite Signal 34.1 / 100 (SELL) 43.9 / 100 (HOLD) Higher Composite CAMP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SLS vs CAMP Buy Guide
SLS BREAKOUT
99d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 74th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live SLS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SLS nor CAMP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.